NCT02849002

Brief Summary

The primary objective of this study is to collect un-blinded BrainPulse recordings from youth and adults that have a confirmed diagnosis of concussion per protocol guidelines in order to improve a concussion detection algorithm previously developed by Jan Medical, Inc. Subjects will be followed for 21 days after the initial injury with BrainPulse recordings to study the subject's recovery process. The symptomatic evaluation, physical examination, and BrainPulse recordings will be entered in a database to assess clinical outcome and device utilization.BrainPulse(TM)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2016

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

July 25, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 29, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2016

Completed
Last Updated

July 7, 2023

Status Verified

July 1, 2023

Enrollment Period

3 months

First QC Date

July 25, 2016

Last Update Submit

July 6, 2023

Conditions

Keywords

Concussion

Outcome Measures

Primary Outcomes (1)

  • Number of BrainPulse recordings from suspected and confirmed concussed subjects

    collect un-blinded BrainPulse recordings from youth and adults that have a confirmed diagnosis of concussion per protocol guidelines in order to improve a concussion detection algorithm previously developed by Jan Medical, Inc.The primary endpoint is to enroll and record BrainPulse signals from 500 subjects with a suspected concussion. To gather sufficiently diverse data, at least 300 participants will have had a confirmed diagnosis of concussion. The data will be used to improve the algorithm for aiding in the diagnosis of concussion.

    Through study completion, expected to be 6 months

Secondary Outcomes (1)

  • Average number of days the signal pattern seen within BrainPulse recordings from confirmed concussed subjects from the initial recording persist over the course of the 21 day follow up period.

    Through study completion, expected to be 1 year]

Study Arms (1)

Interventional Device

The BrainPulse is used on a patient's head to non-invasively detect, amplify and capture the brain motion caused by pulsatile blood flow from the cardiac cycle. The BrainPulse consists of a reusable headset that contains the accelerometers used to measure motion caused by pulsatile blood flow. The system is powered by rechargeable battery pack. The headset is placed on the subject's head and outputs data to a data collector that forwards the data to the computer. Each accelerometer has an attached tip that makes contact with the subject's head through hair. The headset also includes a photoplethysmograph (PPG) that simultaneously captures the subject's heart-rate information. There is no energy delivered to the brain or subject by these highly sensitive sensors.

Device: BrainPulse

Interventions

Jan Medical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle, referred to as the BrainPulse signal. The BrainPulse measures skull acceleration in response to the brain motion using an array of sensors placed on the head.

Also known as: BrainPulse 1100
Interventional Device

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Children and adults, ages 13 and older, who are diagnosed with a concussion or mild Traumatic Brain Injury (mTBI), typically due to a trauma event such as a fall, sports injury, motor vehicle accident, etc.

You may qualify if:

  • Age \> 13 years old and not part of any other vulnerable population such as pregnant women.
  • Suspected or confirmed concussion by medical professional
  • Not more than 3 days since injury/trauma event
  • Willing and able to participate in all required study evaluations and allow access to medical testing and records
  • Signed informed consent/assent, and/or have a legally authorized representative willing to provide informed consent on behalf of the subject.
  • Demonstrates a minimum of 3 of the following symptoms:
  • Headache
  • Pressure in head
  • Dizziness
  • Neck pain
  • Fatigue/ low energy
  • Nausea or vomiting
  • Irritability
  • Difficulty in concentrating/performing tasks
  • Memory impairment
  • +13 more criteria

You may not qualify if:

  • Wound or open laceration on the head in the area of one of the BrainPulse sensors that would impede use of the BrainPulse device
  • Any serious medical condition that in the opinion of the medical professional would impair ability to provide informed consent/assent or otherwise disqualify a patient from participation
  • Currently participating in or planning to participate in another clinical study during the course of the current clinical study.
  • Implantation of any medical device in head (e.g. ventriculoperitoneal shunt)
  • An alternative diagnosis is made other than concussion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konkussion Inc.

Woodbridge, Ontario, L4L9R6, Canada

Location

MeSH Terms

Conditions

Brain Concussion

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Neilank Jha, MD

    Konkussion

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2016

First Posted

July 29, 2016

Study Start

July 14, 2016

Primary Completion

September 29, 2016

Study Completion

September 29, 2016

Last Updated

July 7, 2023

Record last verified: 2023-07

Locations